10 Conditions That Could Soon Be Treated With Cannabis: From Menstrual Cramps To Autism

Cannabis “tampons” could be the ultimate treatment for period pains.

Early this year, the notorious “weed lube” maker Foria launched Foria Relief, a cannabis-infused vaginal suppository (containing only cocoa butter, THC and CBD) that helps ease menstrual cramps without giving users a “psychotropic high” – this means, no trip, just pain relief. The suppositories do not replace traditional tampons, and can be used at the same time as them.

Interestingly, reviews have been very good, with people saying the product provided longer pain relief than traditional painkillers. In a Broadly article, Mish Barber Way declared her cramps had disappeared completely just 20 minutes after inserting the suppository in her body.

Before we continue with the praise of this new product, readers should note that the U.S. FDA had not approved Foria Relief yet, neither has it undergone clinical trials. So far, the suppositories are only available in Colorado and California, and patients are required to present a medical marijuana card or a doctor’s letter to purchase them.

Related Link: Harvard Explains The Health Effects Of Medical And Recreational Use Of Marijuana

“Our intention is to share the powerful medicinal properties of this plant while utilising modern extraction techniques to standardise purity and potency, thereby ensuring a safe and accessible experience for all women,” the company’s website explained.

Beyond Period Pains

Beyond menstrual cramps, marijuana is being used to treat a large number of ailments. Minnesota recently added intractable pain to its list of conditions that could be legally treated with marijuana, and media outlets have reported that that the Department of Health is evaluating the addition of nine other conditions to this list.

Related Link: What Presidential Candidates Think About Marijuana Policy And Legalization

Among the conditions that could soon be treated with marijuana in Minnesota are, according to various reports:

• Arthritis.
• Acquired loss of limb.
• Autism.
• Autism spectrum disorder.
• Diabetes (blood sugar control).
• Ehlers-Danlos syndrome.
• Insomnia.
• Post-Traumatic Stress Disorder.
• Schizophrenia.
• Treatment-resistant depression.

Some stocks related to the marijuana business/biopharm sector include:

• AbbVie Inc ABBV
: cannabis-related drug Marinol.
• Cara Therapeutics Inc CARA: clinical-stage biotech focused on selective targeting kappa opioid receptors.
• Pharmacyte Biotech Inc PMCB: combine Cell-in-a-Box® technology with cannabis constituents.
• OXIS International, Inc. OXIS: cannabis-based drug treatments.
• GW Pharmaceuticals PLC- ADR GWPH: currently two cannabis-based drugs "licensed for use outside the United States," Epidiolex and Sativex.
• Insys Therapeutics Inc INSY: cannabiodiol trial currently in phase II.
• Zynerba Pharmaceuticals Inc ZYNE: developing next-generation synthetic cannabiniod therapies.
• Terra Tech Corp TRTC: cannabis-focused ag company.
• MassRoots Inc MSRT: tech platform for cannabis-related.
• PINEAPPLE EXPRESS COM USD0.001 PNPL: purchase and lease ofcannabis-related businesses.
• CANOPY GROWTH CORP COM NPV TWMJF: produces and sells medical marijuana.
• Cannabis Science Inc CBIS: more info here.
• ORGANIGRAM HLDGS I COM NPV OGRMF: produces and sells medical marijuana.

Full ratings data available on Benzinga Pro.

Disclosure: Javier Hasse holds no interest in any of the securities or entities mentioned above.